Stocks to watch- HDFC Bank, Sun Pharma, Vedanta, Nestle India, IDFC First Bank, KPI Green
时间:2024-06-28 23:33:31 阅读(143)
GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a negative opening on Tuesday. Here’s a look at the key stocks to watch in trade.
Stocks in Focus: GIFT Nifty traded slightly down by 13.50 points or 0.06% at 21,470.50, indicating a lacklustre opening for domestic indices NSE Nifty 50 and BSE Sensex on Tuesday. Previously, on Monday, the NSE Nifty 50 dropped 38 points or 0.18% to settle at 21,418.65, while the BSE Sensex ended lower by 168.66 points or 0.24% to 71,315.09.
HDFC Bank raises a substantial Rs 7,425 crore through its inaugural 10-year infrastructure bond issue, securing funds at a 7.71% coupon rate.
Sun PharmaSun Pharmaceutical Industries acquires a 16.7% stake in Massachusetts-based Lyndra Therapeutics for $30 million, expanding its global presence.
VedantaVedanta board approves a second interim dividend of Rs 11 per share, totaling Rs 4,089 crores; record date set for December 27.
Nestle IndiaNestle India sets a record date of January 5 for a 1:10 stock split, determining shareholders’ entitlement post-approval on October 19.
Devyani InternationalDevyani International ventures into the Thailand market with the acquisition of 274 KFC outlets for Rs 1,066.10 crore; additionally invests Rs 340 crore in its Dubai-based global arm.
IDFC First BankIDFC First Bank receives regulatory approval from the RBI for the merger of IDFC and IDFC Financial Holding Co. with itself.
India GlycolsIndia Glycols secures a major order from oil marketing and oil companies for the supply of 16.55 liters of ethanol, valued at Rs 1,164 crore, under the Ethanol Blended Petrol Programme.
KPI GreenKPI Green initiates a Qualified Institutional Placement (QIP) aiming to raise up to Rs 300 crore, setting the floor price at Rs 1,245 per share, reflecting a 9.64% discount to the previous day’s closing.
Olectra GreentechNational Company Law Tribunal dismisses Olectra Greentech’s petition against MLR Motors for the recovery of Rs 10 crores.
BioconBiocon Biologics, a unit of Biocon, successfully completes the transition of the acquired biosimilars business across 120 countries in advanced and emerging markets.
上一篇:Oil prices climbs after OPEC+ keeps output cut targets, China eases COVID curbs
下一篇:Zomato share price rallies 18%, mcap tops Rs 50,000-cr; Here’s what’s fueling the rally
猜你喜欢
- Oil India shares strain following Q2 Results; Should you buy, hold or sell the stock-
- NSE puts 7 Adani stocks under ASM; what this means for investors, should you buy, sell or hold-
- Low interest rates to keep markets flushed with liquidity; here’s what else is in store for 2021
- Maldives minister’s post on PM Modi’s Lakshadweep visit triggers massive row
- Oil prices crash 56% amid coronavirus breakout, production cut may provide relief in FY21
- Proximity of global AI regulation- Assessing AI safety measures
- NSE Bulk deals, December 23- Landmark Cars, AHL, ZOTA and other major deals that took place on Friday
- Rating- Hold - Rise in slippages a worry for Kotak
- Rajnath Singh set to undertake 3-day visit to UK from Monday